Ala-Kokko et al., "Hepatic Fibrosis in Rats Produced by Carbon Tetrachloride and Dimethylnitrosamine: Observations Suggesting Immunoassays of Serum for the 7S Fragment of Ype IV Collagen area More Sensitive Index of Liver Damage than Immunoassays for the NH.sub.2 -Terminal Propeptide of Type III Procollagen", Hapatology 16:167-172 (1992). |
Ala-Kokko et al., "Single base mutation in the type II procollagen gene (COL2A1) as a cause of primary osteoarthritis associated with a mild chondrodysplasia", Proc. Natl. Acad. Sci, USA 87:6565-6568 (1990). |
Bonadio et al, "Transgenic mouse model of the mild dominant form of osteogenesis imperfecta", Proc. Natl. Acad. Sci, USA 87:6565-6568 (1990). |
Byers, "Brittle bones--fragile molecules: disorders of collagen gen structure and expression", TIG 6:293-300 (1990). |
Chang et al., "Antisense Inhibition of ras p21 Expression that is Sensitive to a Point Mutation", Biochemistry 30:8283-8286 (1991). |
Chiang et al., "Antisense Oligonucleotides Inhibit Intercellular Adhesion Molecule 1 Expression by Two Distinct Mechanisms", J. Biol. Chem. 266:18162-18171 (1991). |
Chomcynski et al., "Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate-Phenol-Chloroform Extraction", Anat. Biochem. 162:156-159 (1987). |
Chu et al., Connective Tissue and Its Heritable Disorders, Chapter 3, Part II, pp. 249-265 (1993). |
Khillan et al., "Transgenic Mice That Express a Mini-gene Version of the Human Gene for Type I Procollagen (COL1A1) Develop a Phenotype Resembling a Lethal Form of Osteogenesis Imperfecta", J. Biol. Chem. 266:23373-23379 (1991). |
Kole et al., "Pre-mRNA splicing as a target for antisense oligonucleotides", Adv. Drug Del. Rev. 6:271-286 (1991). |
Kuivaniemi et al., "Mutations in collagen genes: causes of rare and some common diseases in humans", FASEB J. 5:2052-2060 (1991). |
Marmur et al., "Determination of the Base Composition of Deoxyribonucleic Acid from it Thermal Denaturation Temperature", J. Mol. Biol. 5:109-118 (1962). |
Mooslehner et al., "Two mRNAs of mouse pro .alpha.1(I) collagen gene differ in the size of the 3'-untranslated region", Nucleic Acids Research 16:773 (1988). |
Munroe, "Antisense RNA inhibits splicing of pre-mRNA in vitro", EMBO J. 7:2523-2532 (1988). |
Myers et al., "Cloning a cDNA for the pro-.alpha.2 chain of human type I collagen", Proc. Natl. Acad. Sci USA 78:3516-3520 (1981). |
Olsen et al., "High Levels of Expression of a Minigene Version of the human Pro.alpha.1(I) Collagen Gene in Stably Transfected Mouse Fibroblasts", J. Biol. Chem 266:1117-1121 (1991). |
Orkin, The Molecular Basis of Blood Diseases, G. Stamatoyannopoulous et al. Eds., W.B. Saunders, Philadelphia, pp. 106-126 (1987). |
Prockop et al., Ann N.Y. Acad. Sci, vol. 580, (1990) pp. 330-339. |
Prockop, "Minireview: Mutations That Alter the Primary Structure of Type I Collagen", J. Biol. Chem. 265:15349-15352 (1990). |
Slack et al., "An Upstream Regulatory Region Mediates High-Level,Tissue-Specific Expression of the Human .alpha.1(I) Collagen Gene in Transgenic Mice", Molecular and Cellular Biology, Apr. 1991, pp. 2066-2074. |
Stacy et al., Perinatal lethal osteogenesis imperfecta in transgenic mice bearing an engineered mutant pro-.alpha.1 (I) collagen gene, Nature 332:131-136 (1988). |
Stein et al., "Oligodeoxynucleotides as Inhibitors of Gene Expression: A Review", Cancer Research 48:2659-2668 (1988). |
Sykes, "Bone disease cracks genetics", Nature 348:18-20 (1990). |
Vanderberg et al., "Expression of a partially deleted gene of human type II procollagen (COL2A1)", Proc. Natl. Acad. Sci 88:7640-7644 (1991). |
Vu et al., "Internucleotide Phosphite Sulfurization with Tetraethylthiuram Disulfide, Phosphorothioate Oligonucleotide Synthesis Via Phophoramidite Chemistry", Tetrahedron Letters 32:3005-3008 (1991). |
Vuorio et al., J. Cell. Biochem. Supp. 15A (Jan. 1991) p. 205, Abstract No. B423. |
Westerhausen et al., "Completion of the Last Half of the Structure of the Human Gene for the Pro.alpha.1(I) Chain of Type I Procollagen (COL1A1)", Matrix 11:375-379 (1991). |
Williams et al., "Synthesis and Processing of a Type I Procollagen Containing Shortened Pro-.alpha.1(I) Chains by Fibroblasts form a Patent with Osteogenesis Imperfecta", J. Biol. Chem. 258:5915-5921 (1983). |
Wu et al., "Human-Mouse Interspecies Collagen I Heterotrimer Is Functional During Embryonic Development of Mov13 Mutant Mouse Embryos", Molecular and Cellular Biology 10:1452-1460 (1990). |
Uhlmann et al., "Antisense Oligonucleotides: a new therapeutic principle," Chemical Reviews 90(4):544-579 (1990). |
Nussbaum et al., Abstract No. 1505, 42nd Annual Meeting, San Francisco, CA, The American Society of Human Genetics, Nov. 9-13, 1992. |
Wickstrom, "Strategies for administering targeted therapeutic oligodeoxynucleotides", Tibtech 10:281-287 (1992). |
Ledley et al., "Clinical considerations in the design of protocols for somatic gene therapy", Human Gene Therapy 2:77-83 (1991). |
Prockop et al., Ann. of the NY Acad. of Sci. 580:330-339 (1990). |
Stull RA, et al. "Antigene, ribozyme and aptamer nucleic acid drugs: Progress and prospects." Pharmaceutical Research 12 (4): 465-483., 1995. |
Orkin SH, et al. "Report and Recommendations of the Panel to Assess the NIH Investment in Research on Gene Therapy.", Dec. 7, 1995. |